Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma
gene therapy
orphan drug
pharmacovigilance
safety data
spinal muscular atrophy
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
received:
26
02
2024
revised:
13
03
2024
accepted:
15
03
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
The recent introduction of the innovative therapy, onasemnogene abeparvovec (Zolgensma
Identifiants
pubmed: 38543180
pii: ph17030394
doi: 10.3390/ph17030394
pii:
doi:
Types de publication
Journal Article
Langues
eng